Liquid chromatography-mass spectrometry (LC-MS) trial tags in 30-plex or customized mass-shift configurations serve as essential chemical labeling tools for multiplexed peptide quantification and structural identification. Designed exclusively for laboratory research and analytical characterization, these reagents enable high-throughput comparative profiling across complex biological and synthetic samples.
Liquid chromatography-mass spectrometry (LC-MS) trial tags in 30-plex or customized mass-shift configurations serve as essential chemical labeling tools for multiplexed peptide quantification and structural identification. Designed exclusively for laboratory research and analytical characterization, these reagents enable high-throughput comparative profiling across complex biological and synthetic samples.
In analytical chemistry and proteomic research, LC mass trial tags (frequently evaluated in 30-plex or 30-tag experimental arrays) are specialized chemical labels designed to derivatize primary amines or specific functional groups on peptides prior to liquid chromatography-mass spectrometry (LC-MS) analysis. By attaching distinct chemical moieties with predetermined molecular mass shifts, researchers can pool multiple experimental samples into a single LC-MS run without altering the chemical chromatographic behavior of the analytes.
The primary purpose of a 30-tag trial set is to validate multiplexing efficiency, reporter ion stability, and mass resolution across broad peptide libraries. In high-throughput preclinical investigations, these trial tags allow quantitative comparison across up to 30 distinct condition arms—such as time points, concentration gradients, or enzymatic digestion fractions—while minimizing instrument run time, run-to-run variation, and matrix suppression effects.
The molecular architecture of LC mass trial tags typically consists of three functional regions: an amine-reactive targeting group (such as an N-hydroxysuccinimide ester), a mass normalization balance region, and a stable-isotope-encoded reporter group. During tandem mass spectrometry (MS/MS) fragmentation via collision-induced dissociation (CID) or higher-energy collisional dissociation (HCD), the bond between the reporter and balance regions cleaves cleanly at fixed collision energies.
This controlled fragmentation releases distinct low-mass reporter ions (spanning precise mass-to-charge ratios) while leaving the precursor peptide backbone intact for sequence identification. In a 30-plex arrangement, heavy stable isotopes (such as 13C and 15N) are strategically positioned within the reporter structure, generating 30 isobaric or mass-differentiated signatures. Preclinical in vitro assays demonstrate that this precise isotopic arrangement maintains uniform ionization efficiency across all tagged peptide variants.
Mass spectrometry trial tags play a vital role in validating the purity, stability, and degradation kinetics of synthetic peptides. When investigating novel sequence modifications or structural analogs, researchers utilize liquid chromatography-mass spectrometry (LC-MS) to monitor peptide identity, confirm sequence coverage, and detect potential impurities such as deletion sequences or racemized side-chains.
By employing a 30-tag matrix, analytical laboratories can simultaneously screen baseline peptide stock against various stress conditions—such as freeze-thaw cycling, thermal elevation, pH shifts, or enzymatic cleavage assays. In vitro data indicate that tag-labeled peptides exhibit predictable elution profiles on reverse-phase C18 columns, enabling tight alignment between ultraviolet (UV) absorbance at 214 nm and total ion chromatograms (TIC).
When designing quantitative proteomic or peptide characterization protocols, researchers evaluate several labeling and calibration strategies. While isobaric mass tags provide high-throughput multiplexing capabilities for up to 30 parallel samples, alternative methodologies such as label-free quantification (LFQ) or SILAC (stable isotope labeling by amino acids in cell culture) present distinct operational tradeoffs.
Compared to label-free profiling, 30-plex trial tags eliminate run-to-run retention time drift and instrument drift by co-analyzing all labeled specimens in a single chromatographic injection. When evaluating target compounds within the PX1 Research analytical catalog, analytical teams frequently compare isotopic mass tagging methods against direct quantitative reference standards like BPC-157 analytical grade, isobaric mass tagging reagents, and synthetic peptide standards. This comparative framework ensures optimal selection based on required mass accuracy, dynamic range, and throughput.
Preclinical methodology studies have extensively documented the performance of 30-plex mass tag systems in high-resolution mass spectrometry platforms (including Orbitrap and Q-TOF mass analyzers). In vitro experiments confirm that amine-reactive trial tags achieve labeling efficiencies exceeding 98% under optimized alkaline pH conditions (pH 8.5 in triethylammonium bicarbonate buffer), with minimal unreacted substrate remaining.
Furthermore, comparative literature demonstrates that modern isobaric and mass-shifted tags maintain linear reporter ion signals across three to four orders of magnitude. This broad dynamic range allows researchers to accurately quantify subtle variations in low-abundance target peptides alongside high-abundance matrix proteins without encountering signal saturation or co-isolation interference.
Achieving reproducible results with LC mass trial tags requires meticulous attention to laboratory handling and reaction conditions. Because mass tags are typically supplied as lyophilized, moisture-sensitive powders, reconstitution must be performed using anhydrous organic solvents such as acetonitrile or dimethyl sulfoxide (DMSO) immediately prior to use.
The labeling reaction is conducted by incubating the reconstituted tag solution with the target peptide sample in a non-nucleophilic buffer (e.g., TEAB or HEPES) for 60 to 90 minutes at room temperature. The reaction is subsequently quenched using hydroxylamine solution (5% v/v) to scavenge excess reactive tags and prevent non-specific labeling of tyrosine or serine residues. Detailed step-by-step procedures are outlined in our dedicated reconstitution and storage protocols.
To prevent premature hydrolysis of active ester groups, un-reconstituted trial tags must be stored at -20°C or -80°C in desiccated storage containers containing active silica gel indicators. Lyophilized reagents maintained under these conditions demonstrate chemical stability for up to 24 months from the date of manufacture.
Once dissolved in anhydrous solvent, any unused tag solution should be aliquoted, snap-frozen in liquid nitrogen, and stored at -80°C to minimize loss of reactivity. Avoid repeated freeze-thaw cycles, as ambient humidity rapidly hydrolyzes reactive esters into inactive carboxylic acid derivatives. Laboratories requiring high-volume testing sets can coordinate through our bulk research peptide accounts to ensure batch consistency across long-term trial series.
When purchasing analytical trial tags, mass spectrometry standards, or reference peptides, laboratory researchers must demand verified analytical rigor. Every lot supplied by PX1 Research undergoes strict quality control to guarantee that reagents meet exact chemical specifications required for reproducible research.
Our quality assurance protocol includes mandatory verification by reverse-phase high-performance liquid chromatography (RP-HPLC) to confirm chemical purity (>98%), electrospray ionization mass spectrometry (ESI-MS) to confirm isotopic enrichment and exact mass identity, and chromogenic LAL assays to ensure compliance with strict endotoxin testing methodologies. Every shipment is accompanied by a lot-specific Certificate of Analysis (COA) issued by an ISO 17025 accredited testing facility.
PX1 Research operates state-of-the-art synthesis and analytical facilities compliant with Good Manufacturing Practice (GMP) standards across California and Arizona. By maintaining domestic USA manufacturing and centralized distribution hubs, PX1 eliminates international customs delays and provides reliable same-day dispatch for orders placed before cutoff times.
Whether your research program requires standardized LC-MS trial tag arrays, specialized labeling reagents, or reference compounds such as TB-500 reference standard, PX1 Research delivers full lot traceability, transparent analytical data, and uncompromised purity. All compounds supplied are strictly for laboratory in vitro and preclinical research applications and are never intended for human or veterinary use.
What does 'lc mass,trial tags,30' refer to in laboratory research?
It refers to a 30-plex array or 30-tag trial set of mass spectrometry labeling reagents used in liquid chromatography-mass spectrometry (LC-MS) to multiplex, identify, and quantify peptides in complex research samples.
How do 30-plex mass trial tags function during LC-MS analysis?
The trial tags covalently bind to peptide primary amines. Upon MS/MS fragmentation, they release distinct isotopic reporter ions that allow quantitative comparison across 30 distinct sample conditions in a single LC-MS run.
What solvents are recommended for reconstituting mass trial tags?
Mass trial tags should be reconstituted using anhydrous, HPLC-grade organic solvents such as acetonitrile or dimethyl sulfoxide (DMSO) to prevent hydrolysis of reactive ester groups.
What analytical testing is performed on PX1 Research compounds?
Every lot is verified using RP-HPLC for chemical purity, ESI-MS for exact molecular weight confirmation, and LAL assays for endotoxin quantification, backed by a lot-specific COA from an ISO 17025 accredited laboratory.
How should reconstituted trial tag reagents be stored?
Reconstituted tag solutions should be aliquoted, frozen immediately, and stored at -80°C under desiccated conditions. Repeated freeze-thaw cycles must be avoided to prevent loss of labeling efficiency.
Are LC mass trial tags intended for diagnostic or human use?
No. All compounds provided by PX1 Research, including mass tags and research peptides, are strictly for laboratory in vitro research and analytical evaluation only. They are not for human, clinical, or therapeutic use.
Where are PX1 Research compounds synthesized and shipped from?
PX1 Research compounds are manufactured in domestic USA GMP-compliant facilities and shipped directly from distribution hubs in California and Arizona with same-day shipping options.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.